
In Denmark approximately 3,600 patients are diagnosed with colorectal cancer (CRC) every year. 75-80% of patients may undergo intended curative resection, but the disease recurs in about 40% within five years and the prognosis is poor. Hence, there is a need for biological markers that could be used for detection, evaluation of prognosis, therapy selection and monitoring. The serum proteins of the innate immune system mannan-binding lectin (MBL) and MBL-associated serine protease-2 (MASP-2) are novel biomarkers under validation in CRC. Low preoperative MBL levels are predictive of pneumonia which subsequently is associated with poor survival. High MASP-2 levels predict recurrence and poor survival.
Postoperative Complications, Mannose-Binding Protein-Associated Serine Proteases, Biomarkers, Tumor, Humans, Pneumonia, Neoplasm Recurrence, Local, Colorectal Neoplasms, Prognosis, Mannose-Binding Lectin
Postoperative Complications, Mannose-Binding Protein-Associated Serine Proteases, Biomarkers, Tumor, Humans, Pneumonia, Neoplasm Recurrence, Local, Colorectal Neoplasms, Prognosis, Mannose-Binding Lectin
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
